Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bristol-Myers Squibb
(NY:
BMY
)
58.55
+0.32 (+0.54%)
Streaming Delayed Price
Updated: 10:08 AM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bristol-Myers Squibb
< Previous
1
2
3
4
5
6
7
8
9
...
66
67
Next >
Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
July 23, 2024
Via
Benzinga
AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife
July 23, 2024
The aim is to strengthen their drug pipelines and expand their presence in the world's second-largest pharmaceutical market.
Via
Benzinga
A Glimpse Into The Expert Outlook On Bristol-Myers Squibb Through 4 Analysts
July 22, 2024
Via
Benzinga
3 Defensive Stocks to Shield Your Portfolio in July
July 20, 2024
Fed Chair Jerome Powell’s cautious economic outlook adds to the allure of defensive stocks offering stable long-term returns
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
7 Value Stocks to Buy at a 52-Week Low in July
July 19, 2024
Bottom fishers and contrarians take note: each of these seven value stocks to buy is on sale after recently hitting new 52-week lows.
Via
InvestorPlace
What the Options Market Tells Us About Bristol-Myers Squibb
July 18, 2024
Via
Benzinga
High Dividend 50: Bristol-Myers Squibb
July 16, 2024
This article will examine the prospects of Bristol-Myers as an investment opportunity.
Via
Talk Markets
Bristol-Myers Squibb Unusual Options Activity For July 15
July 15, 2024
Via
Benzinga
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
July 21, 2024
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.
Via
Benzinga
Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity
July 10, 2024
Via
Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
July 09, 2024
Via
Benzinga
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
July 19, 2024
The Nasdaq tumbled amid chip woes.
Via
Investor's Business Daily
Bristol Myers Squibb Receives European Medicines Agency Validation of Application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Unresectable or Advanced Hepatocellular Carcinoma
July 19, 2024
From
Bristol Myers Squibb
Via
Business Wire
Collect $2,000 in Dividends Per Year by Investing $35,000 in These 3 Stocks
July 18, 2024
These stocks all pay more than four times the S&P 500 average.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
US Bancorp Posts Upbeat Earnings, Joins Aehr Test Systems, Hancock Whitney And Other Big Stocks Moving Higher On Wednesday
July 17, 2024
Via
Benzinga
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
July 15, 2024
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Got $500? 2 No-Brainer Growth Stocks to Buy and Hold Forever
July 15, 2024
These businesses are begging to be bought.
Via
The Motley Fool
Week In Review: Foreseen Sells ADC Rights To France's Ipsen In $1 Billion Deal
July 13, 2024
In other news, Sichuan Biokin Pharma has filed for an IPO on the Hong Kong Exchange; more on the Biosecure Act being pushed by US Speaker of the House Johnson.
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
3 High-Yielding Dividend Stocks Near Their 52-Week Lows
July 13, 2024
These stocks all yield more than 3%.
Via
The Motley Fool
2 Pharma Stocks to Buy Hand Over Fist This Month
July 13, 2024
These drugmakers may not be in perfect health right now, but that shouldn't last much longer.
Via
The Motley Fool
3 Under-$10 Biotech Stocks That Could Make You Rich
July 11, 2024
Discover three under-$10 biotech stocks with potential to make you rich with huge returns on investment through an in-depth analysis.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
July 10, 2024
Via
Benzinga
3 Undervalued Stocks Ready for a Breakout This Summer
July 10, 2024
Undervalued breakout stocks are heating up this summer. Discover three hidden gems with strong fundamentals ready to outperform the market.
Via
InvestorPlace
3 Popular Stocks Trading at 52 Week Lows
July 10, 2024
Stocks at 52 week lows could provide value, but it's not always a sure thing.
Via
The Motley Fool
Want $1,000 in Reliable Dividend Income? Invest $11,800 in these 3 Ultra-High-Yield Dividend Stocks.
July 10, 2024
These three dividend payers could deliver buckets of passive income to patient investors.
Via
The Motley Fool
The 7 Best Warren Buffett Stocks to Buy in July 2024
July 09, 2024
Some investors may say value investing is dead, but its never a bad time to look at some of the best Warren Buffett stocks to buy
Via
InvestorPlace
3 High-Yield S&P 500 Dividend Stocks That You Can Buy With $100 Right Now
July 09, 2024
After underperforming the benchmark index these stocks offer high dividend yields that are hard to ignore.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation Day
July 08, 2024
From
Bristol Myers Squibb
Via
Business Wire
3 Defensive Stocks to Buy During the Market Dip
July 08, 2024
Clearway, Bristol-Myers Squibb and Universal Corp. are defensive stocks to buy on the dip, offering stable dividends and significant upside.
Via
InvestorPlace
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in July
July 06, 2024
Adding these dividend payers to your portfolio is a nearly certain way to boost your passive income stream.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
66
67
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.